Mpox Vaccine Interest Survey Prioritization and Data Flow: Maricopa County, Arizona, July-August 2022.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 36893362.
- Also identified by DOI 10.2105/AJPH.2023.307224 and PMC identifier 10088967.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With increasing mpox cases in Maricopa County, Arizona, the county's health department launched a survey on July 11, 2022, to gather eligibility and contact data and provide clinic information to those interested in JYNNEOS as postexposure prophylaxis (PEP) or expanded postexposure prophylaxis(PEP++). Survey data were matched to case and vaccination data. Overall, 343 of the 513 respondents (66.9%) who reported close contact with an mpox case patient received PEP and 1712 of the 3379 respondents (50.7%) who were unsure of their contact status received PEP++. This outreach intervention connected potential close contacts unknown to MCDPH with PEP or PEP++. (<i>Am J Public Health.</i> 2023;113(5):504-508. https://doi.org/10.2105/AJPH.2023.307224).
Medical subject headings
- Mpox, Monkeypox
- Smallpox Vaccine
- Vaccines